Chongqing Beibei Manufacturing Site
52,000m2Area
5Production Lines
260+Employees
Capabilities
Drug Product Capability
Tablet
- IR
- MR
- Double-Tablet
Capsule
- IR
- MR
- Micro-pellet Filler
Injectable
- Ampoule
- Vials for Powder & Liquid
Semisolid
- Cream
- Ointment
- Gel Paste
- Gel Patch
Maximum Annual Output Capacity
- 1B doses
- 60 M doses (HP)
- 200 M doses
- 60 M doses (HP)
- Ampoule: 30 M units
- Small Volume lnjections: 25 M units
- Lyophilized Powder Injections: 3.3 M units
- Cream/Ointment/Gel Paste: 16 MM tubes
- Gel Patch: 35 M tubes
Facilities
Tablets & Capsules

Tablets & Capsules(HP)

Injectable

Semisolid

One Porton One Quality

Compliance standards, Continuous improvement, Customer oriented
Case Studies

Continuous Improvement of Project Life Cycle Management, Benefiting Customers by Reducing Total Cost

Molecular Modeling and Data Science for De-risking and Cost- saving of Pharmaceutical Development

Agile and Fast:Enabling Rapid Market Launch of Innovative Drugs from Preclinical to Commercialization in 18 Months
News
MoreNews2025-01-03
Porton Achieves Higher Scores in the 2024 S & P Global ESG Assessment
More
News2024-12-19
Porton Newsletter | Q4 2024 Recap
More
News2024-12-06
Porton Recognized as an Exemplary Case for Sustainable Development
More
News2024-12-06
Porton is thrilled to announce the launch of its newly redesigned official website
More
News2024-10-14
Driving innovation and excellence in the CDMO industry, Porton at 2024 CPHI Europe
More
News2024-10-01
Porton Newsletter | Q3 2024 Recap
More